about
Effects of an anti-inflammatory VAP-1/SSAO inhibitor, PXS-4728A, on pulmonary neutrophil migrationNew insights into therapeutic strategies for gut microbiota modulation in inflammatory diseasesTumor Necrosis Factor, but Not Neutrophils, Alters the Metabolic Profile in Acute Experimental ArthritisThe central role of the gut microbiota in chronic inflammatory diseases.Beneficial effects of the activation of the angiotensin-(1-7) MAS receptor in a murine model of adriamycin-induced nephropathy.Impaired host defense to Klebsiella pneumoniae infection in mice treated with the PDE4 inhibitor rolipramRepertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury.Skin wound healing is accelerated and scarless in the absence of commensal microbiota.Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome.A Role for Gut Microbiota and the Metabolite-Sensing Receptor GPR43 in a Murine Model of Gout.Evaluation of mucositis induced by irinotecan after microbial colonization in germ-free mice.Microbial influences on epithelial integrity and immune function as a basis for inflammatory diseases.The role of probiotics and prebiotics in inducing gut immunity.Microbiota-Induced Antibodies Are Essential for Host Inflammatory Responsiveness to Sterile and Infectious Stimuli.Transient TLR activation restores inflammatory response and ability to control pulmonary bacterial infection in germfree mice.Inhibition of tissue inflammation and bacterial translocation as one of the protective mechanisms of Saccharomyces boulardii against Salmonella infection in mice.Oral treatment with Saccharomyces cerevisiae strain UFMG 905 modulates immune responses and interferes with signal pathways involved in the activation of inflammation in a murine model of typhoid fever.Effect of Saccharomyces cerevisiae strain UFMG A-905 in experimental model of inflammatory bowel disease.Control of Klebsiella pneumoniae pulmonary infection and immunomodulation by oral treatment with the commensal probiotic Bifidobacterium longum 5(1A).Escherichia coli strain Nissle 1917 ameliorates experimental colitis by modulating intestinal permeability, the inflammatory response and clinical signs in a faecal transplantation model.The role of macrophage migration inhibitory factor in the cascade of events leading to reperfusion-induced inflammatory injury and lethality.APT070 (Mirococept), a membrane-localised complement inhibitor, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury.Influence of Oral and Gut Microbiota in the Health of Menopausal Women.PDE4 inhibition drives resolution of neutrophilic inflammation by inducing apoptosis in a PKA-PI3K/Akt-dependent and NF-kappaB-independent manner.Mechanisms of the anti-inflammatory effects of the natural secosteroids physalins in a model of intestinal ischaemia and reperfusion injury.NF-kappaB plays a major role during the systemic and local acute inflammatory response following intestinal reperfusion injury.The required role of endogenously produced lipoxin A4 and annexin-1 for the production of IL-10 and inflammatory hyporesponsiveness in mice.Mechanisms of the anti-inflammatory actions of the angiotensin type 1 receptor antagonist losartan in experimental models of arthritis.Effects of the treatment with glibenclamide, an ATP-sensitive potassium channel blocker, on intestinal ischemia and reperfusion injury.The chemokine receptors CXCR1/CXCR2 modulate antigen-induced arthritis by regulating adhesion of neutrophils to the synovial microvasculature.Treatment with atorvastatin provides additional benefits to imipenem in a model of Gram-negative pneumonia induced by Klebsiella pneumoniae in mice.The cytosolic sensor STING is required for intestinal homeostasis and control of inflammation.Evaluation of in vitro antagonism and of in vivo immune modulation and protection against pathogenic experimental challenge of two probiotic strains of Bifidobacterium animalis var. lactis.Schistosoma mansoni SmKI-1 serine protease inhibitor binds to elastase and impairs neutrophil function and inflammation.Tissue macrophages as mediators of a healthy relationship with gut commensal microbiota.Bifidobacterium longum subsp. infantis BB-02 attenuates acute murine experimental model of inflammatory bowel disease.Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis.Dietary fiber and the short-chain fatty acid acetate promote resolution of neutrophilic inflammation in a model of gout in mice.The Metabolic Sensor GPR43 Receptor Plays a Role in the Control of Klebsiella pneumoniae Infection in the Lung.Evaluating the effects of refined carbohydrate and fat diets with acute ethanol consumption using a mouse model of alcoholic liver injury.
P50
Q21146674-DE7745FF-3098-4605-A6EA-DA5C8220D935Q28079638-C2B03F8B-02FB-497C-BC4F-F26CA01B1466Q28552434-06D2C4FF-0552-43D6-A3B3-59891636B9EFQ34305760-C76426EE-6E8E-41B3-8FF4-9E1DC95467BFQ34770468-99191BDB-3772-4D85-86FA-947B729CAAD6Q35045854-6FE06DD8-A943-484D-A9AC-23CABAC3C5E3Q35047585-83F5F0CC-1438-40CA-9618-2CD3A27A3B29Q35344485-B6DCA6B6-69C8-4F33-8777-725E4A8ECC15Q35591373-FEC95F23-F647-419B-AC41-C866415FE490Q35614971-F63FEB5D-84E1-4931-8F91-D3471430C7E1Q35725360-7BEAC925-2287-4B66-8100-94092DC639DEQ37968299-0871BF7A-EFA8-4F39-AC65-A640CC0D689CQ38174603-4827D16B-265C-4D7F-8EA7-9EF69DF21450Q38829718-36E5ACC8-8FF9-42E5-9F9B-B9A1F812C7CDQ39291435-122A5150-566C-4A1E-A0B5-A852D044FB5CQ40258638-F241C598-5099-4219-9743-1C245D50FFCFQ40337270-1CCDA8C7-B00B-447B-89ED-B0984C4A5932Q40591128-EB1DCFB4-81CD-4019-B334-84D97B3213ACQ40918154-584FE9C4-8E0E-4778-89FF-FC46A141355EQ40982304-D0B23209-D8AE-42CC-BFA6-45CEFC018160Q41309222-CD7A8194-A2C8-4167-8D7A-CBF2038108AAQ42121465-F69A38EF-834D-4C03-8F8A-220F1989EAD2Q42369136-A511F4C0-56F5-48F7-AFAE-0CF2663F978AQ43183443-E67F53D8-1040-4D60-BDF1-7B15946B6EA4Q43261376-BE8D9187-ACC2-4217-A105-3A79AE1D185EQ43261466-639AEC95-CED6-46A4-9C24-F0E1351E367AQ43643070-AEFD9FE9-E8AE-46C0-BDDE-1CE3070EE3B1Q44429256-C63AC54A-6B8E-41BD-94A4-5E386251BEB7Q45260180-9259FBB4-C9B8-4669-9CCF-19E4AE5EE078Q46454014-8DDC036C-6490-4FF5-AF9D-E6A6FFB161D2Q49791943-F1AF7E99-D685-4577-91B9-478CAB0256CCQ49925661-3ADE532D-94ED-49AE-B23D-8F8BEE37F1D0Q50046192-3889A1D4-875E-493F-A519-60B366129F46Q50099311-FBD4ACF3-7259-4AC1-943D-DF8D8F02A6C2Q50108409-837BAE33-C5C6-4AF3-BB5E-8DD9C4F23624Q51035866-F8E3CE08-1A23-4D53-8419-E6D30295441EQ51538337-F73E9974-D77B-45CF-87A7-9FEFB93062F8Q51590511-D1804E09-6FB6-4514-A139-E2B475645EA6Q51743237-35E73096-DD2B-4337-869D-EA53A8E41120Q52822387-DC3723B1-CE06-47DE-BEFC-B5A85E20549B
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Angélica T Vieira
@ast
Angélica T Vieira
@en
Angélica T Vieira
@es
Angélica T Vieira
@nl
type
label
Angélica T Vieira
@ast
Angélica T Vieira
@en
Angélica T Vieira
@es
Angélica T Vieira
@nl
prefLabel
Angélica T Vieira
@ast
Angélica T Vieira
@en
Angélica T Vieira
@es
Angélica T Vieira
@nl
P1053
A-6227-2015
P106
P21
P31
P3829
P496
0000-0002-4556-7671